Breaking News

Dipharma Receives 2nd GMP Certification from Brazilian ANVISA

The Caronno Pertusella site is the second Dipharma facility to receive ANVISA certification.

Dipharma Francis S.r.l., a contract development and manufacturing organization (CDMO) and a global manufacturer of active pharmaceutical ingredients (APIs), reported that its production site in Caronno Pertusella, near Milan, Italy, has received the good manufacturing practice (GMP) certification – CBPF (Certificado de Boas Práticas de Fabricação) – from the regulatory authority of Brazil, ANVISA (Agência Nacional de Vigilância Sanitária). The company received a previous authoriza...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters